What is the effect of alternative graphical displays used to present the benefits of antibiotics for sore throat on decisions about whether to use them?

ISRCTN ISRCTN58507086
DOI https://doi.org/10.1186/ISRCTN58507086
Protocol serial number N/A
Sponsor Norwegian Knowledge Centre for the Health Services (Norway)
Funder Norwegian Research Council (Norway)
Submission date
09/03/2007
Registration date
04/05/2007
Last edited
02/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms Cheryl Carling
Scientific

PO box 7004
St Olavs Plass
Oslo
N-0130
Norway

Phone +47 98627327
Email cheryl.carling@kunnskapssenteret.no

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymHIPPO (Health Information Project, Presentation Online)
Study objectivesThe null hypotheses for this study are that in terms of congruence between peoples' values and treatment decisions there is no difference between the following graphical displays used to present the benefits of antibiotics for sore throat:
1. “Faces at 3 days” and “Bar graphs at 3 days”
2. “Bar graphs of Duration of symptoms” and “Bar graphs at 3 days”, and
3. ”Bar graphs at 0, 3 and 7 days” and “Bar graphs at 3 days.”
Ethics approval(s)The University at Buffalo (New York, USA), Health Sciences Institutional Review Board, approved on 15 May 2002.
Health condition(s) or problem(s) studiedSore throat (hypothetical scenario)
InterventionPresentations of graphical displays showing evidence of penicillin's effect on sore throat.
Intervention typeOther
Primary outcome measure(s)

Hypothetical treatment decision to take or not to take penicillin.

Key secondary outcome measure(s)

Understanding of and satisfaction with information, and preferred graphical display.

Completion date31/10/2004

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexNot Specified
Target sample size at registration3000
Key inclusion criteriaFluency in Norwegian and at least 18 years of age.
Key exclusion criteriaPrevious participation in this trial.
Date of first enrolment01/09/2004
Date of final enrolment31/10/2004

Locations

Countries of recruitment

  • Norway

Study participating centre

PO box 7004
Oslo
N-0130
Norway

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2009 Yes No